ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 125 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,675 | -3.0% | 10,596 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $6,878 | -61.8% | 10,596 | 0.0% | 0.00% | -66.7% |
| Q3 2022 | $18,000 | +38.5% | 10,596 | 0.0% | 0.01% | +50.0% |
| Q2 2022 | $13,000 | +85.7% | 10,596 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $7,000 | -41.7% | 10,596 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $12,000 | -36.8% | 10,596 | 0.0% | 0.00% | -42.9% |
| Q3 2021 | $19,000 | – | 10,596 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $51,946,000 | 2.80% |
| MILLER VALUE PARTNERS, LLC | 4,900,721 | $26,219,000 | 1.15% |
| MSD Partners, L.P. | 3,410,500 | $18,246,000 | 0.92% |
| Michael & Susan Dell Foundation | 66,749 | $357,000 | 0.26% |
| Glacier Peak Capital LLC | 68,043 | $364,000 | 0.21% |
| Vident Investment Advisory, LLC | 114,980 | $615,000 | 0.08% |
| SFMG, LLC | 62,433 | $334,000 | 0.07% |
| Virtus ETF Advisers LLC | 40,359 | $216,000 | 0.06% |
| Steward Partners Investment Advisory, LLC | 23,187 | $124,000 | 0.06% |
| O'Dell Group, LLC | 10,142 | $54,000 | 0.05% |